Platelet count and risk of major bleeding in venous thromboembolism
Håkon S. Johnsen, Sigrid K. Brækkan, Vânia M. Morelli, John‐Bjarne Hansen
Abstract
/L), and exclusion of patients with cancer yielded similar results. When platelet count was measured on average 7 years before a VTE, the corresponding HR was 2.5 (95% CI 0.9-6.7). Our results suggest that increasing platelet count, assessed several years before and at VTE diagnosis, is associated with a higher risk of major bleeding, and could be a stable individual marker of major bleeding risk in VTE-patients.
Topics & Concepts
MedicineQuartileInternal medicinePlateletHazard ratioConfidence intervalIncidence (geometry)Major bleedingProportional hazards modelGastroenterologyMyocardial infarctionPhysicsOpticsVenous Thromboembolism Diagnosis and ManagementAtrial Fibrillation Management and OutcomesBlood Coagulation and Thrombosis Mechanisms